Insider Trades36 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Sell | VYGR | Alfred Sandrock | President and CEO | 11,511 | $3.87 | $191.5M | -42.88% | +9.92% | $44.5K | -2.38% | — | Sell Now |
| Feb 24, 2026 | Sell | VYGR | Todd Alfred Carter | Chief Scientific Officer | 4,174 | $3.76 | $191.5M | -42.88% | +9.92% | $15.7K | -2.78% | — | Sell Now |
| Feb 24, 2026 | Sell | VYGR | Nathan D. Jorgensen | Chief Financial Officer | 4,668 | $3.77 | $191.5M | -42.88% | +9.92% | $17.6K | -2.99% | — | Sell Now |
| Feb 24, 2026 | Sell | VYGR | Robin Swartz | COO & CBO | 6,458 | $3.77 | $191.5M | -42.88% | +9.92% | $24.3K | -3.13% | — | Sell Now |
| Feb 24, 2026 | Sell | VYGR | Alfred Sandrock | President and CEO | 14,197 | $3.79 | $191.5M | -42.88% | +9.92% | $53.8K | -2.85% | — | Sell Now |
| Feb 18, 2026 | Sell | VYGR | Todd Alfred Carter | Chief Scientific Officer | 3,301 | $3.44 | $191.5M | -42.88% | +9.92% | $11.4K | -2.15% | — | Sell Now |
| Feb 18, 2026 | Sell | VYGR | Robin Swartz | COO & CBO | 3,882 | $3.44 | $191.5M | -42.88% | +9.92% | $13.4K | -1.85% | — | Sell Now |
| Feb 18, 2026 | Sell | VYGR | Alfred Sandrock | President and CEO | 11,732 | $3.41 | $191.5M | -42.88% | +9.92% | $40.0K | -2.30% | — | Sell Now |
| Feb 10, 2026 | Sell | VYGR | Todd Alfred Carter | Chief Scientific Officer | 3,525 | $3.85 | $191.5M | -42.88% | +9.92% | $13.6K | -2.25% | — | Sell Now |
| Feb 10, 2026 | Sell | VYGR | Robin Swartz | COO & CBO | 4,569 | $3.85 | $191.5M | -42.88% | +9.92% | $17.6K | -2.13% | — | Sell Now |
| Feb 10, 2026 | Sell | VYGR | Alfred Sandrock | President and CEO | 12,192 | $3.78 | $191.5M | -42.88% | +9.92% | $46.1K | -2.33% | — | Sell Now |
| Oct 3, 2025 | Sell | VYGR | Nathan D. Jorgensen | Chief Financial Officer | 7,666 | $4.78 | $191.5M | -42.88% | +9.92% | $36.6K | -5.83% | — | Sell Now |
| Aug 18, 2025 | Sell | VYGR | Toby Ferguson | Chief Medical Officer | 19,000 | $3.73 | $191.5M | -42.88% | +9.92% | $70.9K | -12.03% | — | Sell Now |
| Apr 2, 2025 | Sell | VYGR | Toby Ferguson | Chief Medical Officer | 10,086 | $3.43 | $191.5M | -42.88% | +9.92% | $34.6K | -6.00% | — | Sell Now |
| Apr 2, 2025 | Sell | VYGR | Alfred Sandrock | President and CEO | 10,885 | $3.43 | $191.5M | -42.88% | +9.92% | $37.3K | -2.46% | — | Sell Now |
| Feb 20, 2025 | Sell | VYGR | Todd Alfred Carter | Chief Scientific Officer | 3,305 | $4.26 | $191.5M | -42.88% | +9.92% | $14.1K | -1.91% | — | Sell Now |
| Feb 20, 2025 | Sell | VYGR | Robin Swartz | COO & CBO | 3,894 | $4.25 | $191.5M | -42.88% | +9.92% | $16.5K | -1.59% | — | Sell Now |
| Feb 20, 2025 | Sell | VYGR | Alfred Sandrock | President and CEO | 11,702 | $4.24 | $191.5M | -42.88% | +9.92% | $49.6K | -1.96% | — | Sell Now |
| Feb 11, 2025 | Sell | VYGR | Sandell Jacquelyn Fahey | Chief Legal Officer | 4,358 | $4.45 | $191.5M | -42.88% | +9.92% | $19.4K | -5.07% | — | Sell Now |
| Feb 11, 2025 | Sell | VYGR | Todd Alfred Carter | Chief Scientific Officer | 5,413 | $4.45 | $191.5M | -42.88% | +9.92% | $24.1K | -6.26% | — | Sell Now |
| Feb 11, 2025 | Sell | VYGR | Robin Swartz | COO & CBO | 6,950 | $4.45 | $191.5M | -42.88% | +9.92% | $30.9K | -6.36% | — | Sell Now |
| Feb 11, 2025 | Sell | VYGR | Alfred Sandrock | President & CEO | 16,644 | $4.45 | $191.5M | -42.88% | +9.92% | $74.1K | -5.12% | — | Sell Now |
| Jan 14, 2025 | Sell | VYGR | Todd Alfred Carter | Chief Scientific Officer | 1,191 | $5.13 | $191.5M | -42.88% | +9.92% | $6.1K | -1.36% | — | Sell Now |
| Jan 14, 2025 | Sell | VYGR | Robin Swartz | COO & CBO | 3,087 | $5.09 | $191.5M | -42.88% | +9.92% | $15.7K | -2.75% | — | Sell Now |
| Dec 23, 2024 | Sell | VYGR | Robin Swartz | COO&CBO | 6,500 | $5.65 | $191.5M | -42.88% | +9.92% | $36.7K | -5.47% | — | Sell Now |
| Oct 2, 2024 | Sell | VYGR | Sandell Jacquelyn Fahey | Chief Legal Officer | 5,999 | $5.82 | $191.5M | -42.88% | +9.92% | $34.9K | -6.52% | — | Sell Now |
| Apr 2, 2024 | Sell | VYGR | Robin Swartz | Chief Operating Officer | 1,357 | $9.88 | $191.5M | -42.88% | +9.92% | $13.4K | -1.15% | — | Sell Now |
| Apr 2, 2024 | Sell | VYGR | Alfred Sandrock | President and CEO | 12,115 | $9.86 | $191.5M | -42.88% | +9.92% | $119.5K | -3.62% | — | Sell Now |
| Feb 21, 2024 | Sell | VYGR | Peter P. Pfreundschuh | Chief Financial Officer | 3,764 | $7.46 | $191.5M | -42.88% | +9.92% | $28.1K | -2.10% | — | Sell Now |
| Feb 21, 2024 | Sell | VYGR | Robin Swartz | Chief Operating Officer | 3,966 | $7.45 | $191.5M | -42.88% | +9.92% | $29.5K | -3.24% | — | Sell Now |
| Feb 21, 2024 | Sell | VYGR | Alfred Sandrock | President and CEO | 13,033 | $7.46 | $191.5M | -42.88% | +9.92% | $97.2K | -3.75% | — | Sell Now |
| Feb 20, 2024 | Sell | VYGR | Todd Alfred Carter | Chief Scientific Officer | 3,967 | $7.50 | $191.5M | -42.88% | +9.92% | $29.8K | -2.17% | — | Sell Now |
| Jan 17, 2024 | Sell | VYGR | Todd Alfred Carter | Chief Scientific Officer | 1,266 | $7.18 | $191.5M | -42.88% | +9.92% | $9.1K | -2.33% | — | Sell Now |
| Jan 17, 2024 | Sell | VYGR | Robin Swartz | Chief Operating Officer | 2,543 | $7.15 | $191.5M | -42.88% | +9.92% | $18.2K | -3.40% | — | Sell Now |
| Oct 3, 2023 | Sell | VYGR | Peter P. Pfreundschuh | Chief Financial Officer | 13,567 | $6.99 | $191.5M | -42.88% | +9.92% | $94.8K | -8.32% | — | Sell Now |
| Sep 15, 2023 | Sell | VYGR | Todd Alfred Carter | Chief Scientific Officer | 15,500 | $6.45 | $191.5M | -42.88% | +9.92% | $99.9K | -3.34% | — | Sell Now |